Joined Cases Cā611/22 P and Cā625/22 P ā Illumina/Grail: The Continued Search for the Panacea to the Killer Acquisition Conundrum
Killers Interrupted: Stopping Killer Acquisitions in the Pharmaceutical Industry via IP Re-Release Clauses